Skip to main content
. 2016 Mar 25;21(4):404. doi: 10.3390/molecules21040404

Figure 9.

Figure 9

Inhibition (%) of each one of the five compounds (1β,10β-epoxydesacetoxymatricarin (CP1), leucodin (CP2), 5-demethylsinensetin (CP3), 2-(3,4-dimethoxy-phenyl)-3-hydroxy-5,6,7-trimethoxy-chromen-4-one (CP4) and salvigenin (CP5)) plotted against the tested concentrations (0, 2.5, 5, 10, 20, 40, 80 μM).